Successful Treatment of Acromegaly and Associated Hypogonadism with First-Line Clomiphene Therapy
Clomiphene citrate (CC) has been reported as an effective add-on therapy to somatostatin analogs and dopamine agonists in patients with acromegaly accompanied by hypogonadism; its use as a single agent to treat acromegaly and associated hypogonadism following incomplete surgery has not been previous...
Main Authors: | Juan D. Palacios, Ricardo J. Komotar, Atil Y. Kargi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/7925019 |
Similar Items
-
Clomiphene citrate treatment for late onset hypogonadism: rise and fall
by: Marcelo Marconi, et al. -
Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
by: Pranav Dadhich, et al.
Published: (2017-01-01) -
Clomiphene citrate treatment outcomes in Taiwanese hypogonadal men: A single-center preliminary report
by: Jiun-Siang Tan, et al.
Published: (2017-03-01) -
The strange case of a patient affected by acromegaly with osteoporomalacia without hypogonadism
by: S. Caprio, et al.
Published: (2011-09-01) -
Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study
by: Trinh TS, et al.
Published: (2021-06-01)